Results 101 to 110 of about 9,468 (203)

Pathological lymphangiogenesis models using Prox1-tdTomato mouse.

open access: yes, 2016
(A-E) Bladder lymphangiogenesis model: Adult Prox1-tdTomato mice were i.p. injected with phosphate-buffered saline (A,C) or cyclophosphamide (B,D) at days 1 and 4. At day 9, lymphatic vessels in their bladders were visualized.
Young-Kwon Hong (158165)   +20 more
core   +1 more source

Pannexin1 deletion in lymphatic endothelium affects lymphatic function in a sex‐dependent manner

open access: yesPhysiological Reports
The lymphatic network of capillaries and collecting vessels ensures tissue fluid homeostasis, absorption of dietary fats and trafficking of immune cells.
Avigail Ehrlich   +5 more
doaj   +1 more source

Correlation between clinicopathological parameters and PROX1 expression.

open access: yes, 2014
Correlation between clinicopathological parameters and PROX1 expression.
Youhua Xie (405867)   +9 more
core   +1 more source

Expression of PROX1 in the striatum at P30.

open access: yes, 2013
(A) PROX1 labels most Venus+ve striatal interneurons (arrows) in the Dlx1-Venusfl mouse, and some oligodendrocyte lineage cells (arrowheads). PROX1+ve interneurons include the MGE-derived subtypes expressing PV (B) and NPY (C).
Anna Noren Rubin (470529)   +1 more
core   +1 more source

PROX1 단백질에 중화 활성을 갖는 결합 분자

open access: yes
The present disclosure relates to a PROX1 (Prospero homeobox protein 1) protein binding molecule. More specifically, the binding molecule of the present disclosure relates to a binding molecule having excellent binding ability to the PROX1 protein and ...
Lee, Eun-Jung, Kim, Jin Woo
core   +1 more source

Topical tissue nanotransfection of Prox1 is effective in the prophylactic management of lymphedema

open access: yesMolecular Therapy Nucleic Acids
Lymphedema is chronic limb swelling resulting from lymphatic dysfunction. There is no cure for the disease. Clinically, a preventive surgical approach called immediate lymphatic reconstruction (ILR) has gained traction. Experimental gene-based therapeutic approaches (e.g., using viral vectors) have had limited translational applicability.
Ganesh Mohan   +9 more
openaire   +4 more sources

PROX1-säätelytekijä suojaa suoliston kasvainkantasoluja sekä paksu- ja peräsuolen syövän soluja säteilyn aiheuttamilta vaurioilta

open access: yes, 2023
Paksu- ja peräsuolen syöpä (kolorektaalisyöpä) on maailman kolmanneksi yleisin syöpä. Kaikista kolorektaalisyöpäpotilaista on elossa noin 68 % viiden vuoden kuluttua diagnoosista. Noin puolet kaikista syöpäpotilaista saa sädehoitoa.
González-Loyola, Alejandra   +8 more
core  

Effects of Prox1 loss-of function in the vestibular epithelia.

open access: yes, 2013
A. X-gal staining of E14.5 Prox1 heterozygous embryos reveals β-galactosidase activity in the anterior (AC) and horizontal (HC) parts of the canal cristae. B. Although morphologically normal, a reduction in the size of the crista epithelia is detected of
Miriam Dillard (366841)   +4 more
core   +1 more source

Control of Lymphangiogenesis by Prox1

open access: yesDevelopmental Biology, 2011
Wang, Yingdi   +2 more
openaire   +1 more source

Anti-PROX1

open access: yes
The text discusses a scientific breakthrough developed by KAIST researchers in the field of retinal regeneration. It explains that millions of people suffer from retinal diseases that can lead to vision loss, and that there is currently no effective ...
Mora Rochín, Ruth
core  

Home - About - Disclaimer - Privacy